Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults
Clinical trial NCT07249463 · RECRUITING
Trial details
- NCT number
- NCT07249463
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-08
- Primary completion
- 2027-03-02
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.